Drug interaction study in 14 healthy men tests new compound
NCT ID NCT04714073
First seen Jun 25, 2026 · Last updated Jun 25, 2026
Summary
This completed phase 1 trial enrolled 14 healthy male volunteers to see how the antifungal drug itraconazole changes the levels of an experimental drug called BI 706321 in the blood. Participants took BI 706321 alone and then again after several days of itraconazole. The study measured drug concentrations over time to understand the interaction, but it was not designed to treat any condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CRS Clinical Research Services Mannheim GmbH
Mannheim, 68167, Germany
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
BI 706321 and itraconazole
What this could lead to
If successful, this study could help determine the right dosing for future trials of BI 706321 when taken with drugs like itraconazole.
What could go wrong
This is a very early, small study in healthy volunteers, not patients. It only looks at drug levels, not safety or effectiveness for any disease.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.